Tyler J. Marquart, Ph.D. - Publications
Affiliations: | 2014 | Biochemistry | Saint Louis University, St. Louis, MO, United States |
Area:
Biochemistry, Molecular Biology, Cell BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Baldan A, Gonen A, Choung C, Que X, Marquart TJ, Hernandez I, Bjorkhem I, Ford DA, Witztum JL, Tarling EJ. ABCG1 is required for pulmonary B-1 B cell and natural antibody homeostasis. Journal of Immunology (Baltimore, Md. : 1950). 193: 5637-48. PMID 25339664 DOI: 10.4049/Jimmunol.1400606 | 0.568 | |||
2014 | Langhi C, Marquart TJ, Allen RM, Baldán A. Perilipin-5 is regulated by statins and controls triglyceride contents in the hepatocyte. Journal of Hepatology. 61: 358-65. PMID 24768901 DOI: 10.1016/J.Jhep.2014.04.009 | 0.587 | |||
2014 | Allen RM, Marquart TJ, Jesse JJ, Baldán A. Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33. Circulation Research. 115: 10-22. PMID 24753547 DOI: 10.1161/Circresaha.115.303100 | 0.686 | |||
2013 | Marquart TJ, Wu J, Lusis AJ, Baldán Á. Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 33: 455-8. PMID 23288159 DOI: 10.1161/Atvbaha.112.300639 | 0.695 | |||
2012 | Allen RM, Marquart TJ, Albert CJ, Suchy FJ, Wang DQ, Ananthanarayanan M, Ford DA, Baldán A. miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity. Embo Molecular Medicine. 4: 882-95. PMID 22767443 DOI: 10.1002/Emmm.201201228 | 0.688 | |||
2010 | Marquart TJ, Allen RM, Ory DS, Baldán A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proceedings of the National Academy of Sciences of the United States of America. 107: 12228-32. PMID 20566875 DOI: 10.1073/Pnas.1005191107 | 0.696 | |||
Show low-probability matches. |